New research from MSK provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; and more: bit.ly/42mhSft

Patients with HER2+ metastatic breast cancer face a high risk of death due to CNS involvement, and those with CNS-only disease had longer overall survival. ja.ma/42DHmF4 Rabih Bou-Nassif

incredibly honored to have the opportunity to present our work at the E2M session at AANS 2025! #AANS2025 Neurosurgery at Memorial Sloan Kettering

An incredible future ENT doctor right here 👏🏼

Do not miss out on this incredible opportunity!

I am grateful for all I have. Been beyond lucky for the life I lead. Johnny is amazing and Jake does an incredible job with this article!! “I Hope Your Team Sucks and Loses": Inside the Head of John Kruk phillymag.com/news/2025/03/2…

Had a spectacular time at the Jefferson Neurosurgery 3rd Annual Neurosurgery Bootcamp!! I definitely feel more prepared and confident for my sub-Is this summer 💪🏾 Grateful for the relationships made today— new and old — and excited for the upcoming cycle!! 👩🏾‍⚕️🧠 Thank you Thomas Jefferson

grateful to have had the opportunity to attend the Jefferson Neurosurgery sub-i bootcamp this past weekend! had a great time & learned a ton. excited to head back for my sub-i this fall!

Was great to hear Ali Toth give her masters thesis presentation and get a sneak peek at the work she’ll present at #AANS2025 next week. Great work!

so proud of my colleague Sanjeev Herr, MS (he/him) for presenting his masters thesis today! excited to see this work at #AANS2025

Incredible work and an incredible job presenting her research from her research year at MSK! An amazing future neurosurgery applicant. Ali Toth #AANS2025

Had the privilege to watch Sanjeev Herr, MS (he/him) present & receive an award for his hard work! Incredible study from an even more incredible person #AANS2025

Super proud of Ali Toth on excellent presentation AANS NS Tumor Section & Master's eval'ing radiomic features vs multidisciplinary consensus in predicting #CNS #melanoma post-RT recurrence vs necrosis/heme. 🚨2026 nsgy applicant alert-she will match highly! Brain Metastasis Program @ MSK

On the heels of practice-changing #DB-09 & #ASCENT-04 at #ASC025, pleased to share new review on the role of #ADCs in #brainmets, increasingly key survival determinant in pts w met cancers link.springer.com/article/10.100… #bcsm #lcsm #oncoalert Neurosurgery at Memorial Sloan Kettering MSK Department of Medicine Memorial Sloan Kettering Radiation Oncology

Heading to the airport to catch a plane to AHN Neuroscience Institute for my first neurosurgery Sub-I. There are not enough words to express the gratitude that I have for my research year in the Shawn Hervey-Jumper lab. Incredible group, work and mentorship. Feeling blessed.

incredibly grateful to have had the opportunity to spend my research year Neurosurgery at Memorial Sloan Kettering. I can't thank Nelson Moss and the team enough for all the mentorship and support along the way. I had an amazing year of growing & learning, with even better people. now on to sub-is!

Tom McCarthy Yea Tom, can you make a call? You ain’t doing nothing tonight!!!

had the honor of presenting our study on melanoma brain metastases at #SNOASCO2025 incredibly grateful for the opportunity to present alongside so many inspiring leaders in the field! excited to keep learning & contributing in advancing care for patients Brain Metastasis Program @ MSK Nelson Moss

As I prep to start my second away and my third Sub-I tomorrow, I figured I would re-introduce myself. Hello #MedTwitter (#MedX ?)! My name is Sanjeev and I am an MS4 Drexel University College of Medicine . I will be applying to #Neurosurgery this fall for #Match2026. 🇵🇷🏳️‍🌈

excited to have our work published in JNIS!